We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+1.17%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$47.1B
AUM Growth
-$899M
(-1.9%)
Cap. Flow
-$982M
Cap. Flow
% of AUM
-2.08%
Top 10 Holdings %
Top 10 Hldgs %
35.43%
Holding
967
New
122
Increased
219
Reduced
464
Closed
97
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$250M |
| 2 |
Starbucks
SBUX
|
+$152M |
| 3 |
CERN
Cerner Corp
CERN
|
+$122M |
| 4 |
Colgate-Palmolive
CL
|
+$87.1M |
| 5 |
Procter & Gamble
PG
|
+$77.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$456M |
| 2 |
Cisco
CSCO
|
+$392M |
| 3 |
Analog Devices
ADI
|
+$151M |
| 4 |
United Parcel Service
UPS
|
+$148M |
| 5 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$89.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.05% |
| 2 | Consumer Discretionary | 15.92% |
| 3 | Financials | 12.69% |
| 4 | Healthcare | 12.47% |
| 5 | Communication Services | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Western Alliance Bancorporation
WAL
$8.87B
| $9.62M | 0.02% |
165,527
-2,962
| -2% | -$175K |
|
402
Methode Electronics
MEI
$592M
| $9.62M | 0.02% |
245,924
+2,529
| +1% | +$103K |
|
403
Broadridge
BR
$19B
| $9.57M | 0.02% |
87,284
-1,563
| -2% | -$155K |
|
404
Rexford Industrial Realty
REXR
$8.19B
| $9.57M | 0.02% |
332,334
+456
| +0.1% | +$12.9K |
|
405
Ingersoll Rand
IR
$33.7B
| $9.51M | 0.02% |
309,922
-53,279
| -15% | -$1.78M |
|
406
Williams Companies
WMB
$86.1B
| $9.51M | 0.02% |
382,365
+299,697
| +363% | +$8.84M |
|
407
Viavi Solutions
VIAV
$9.66B
| $9.47M | 0.02% |
974,296
+10,230
| +1% | +$97.4K |
|
408
Ashland
ASH
$3.5B
| $9.41M | 0.02% |
134,896
+27,336
| +25% | +$1.97M |
|
409
Neurocrine Biosciences
NBIX
$16.6B
| $9.35M | 0.02% |
112,763
-2,016
| -2% | -$170K |
|
|
DBD
410
DELISTED
Diebold Nixdorf Incorporated
DBD
| $9.3M | 0.02% |
603,895
-98,992
| -14% | -$1.65M |
|
|
AUD
411
DELISTED
Audacy, Inc.
AUD
| $9.28M | 0.02% |
961,933
+54,208
| +6% | +$563K |
|
412
Aclaris Therapeutics
ACRS
$869M
| $9.24M | 0.02% |
527,228
-18,650
| -3% | -$395K |
|
413
Cemex
CX
$16.3B
| $9.23M | 0.02% |
+1,394,104
| New | +$10.4M |
|
|
TIVO
414
DELISTED
Tivo Inc
TIVO
| $9.2M | 0.02% |
679,106
+6,691
| +1% | +$95.5K |
|
|
GRA
415
DELISTED
W.R. Grace & Co.
GRA
| $9.13M | 0.02% |
149,189
-29,029
| -16% | -$1.99M |
|
416
EPAM Systems
EPAM
$5.03B
| $9.12M | 0.02% |
79,634
+19,651
| +33% | +$2.25M |
|
417
OceanFirst Financial
OCFC
$1.91B
| $9.08M | 0.02% |
339,333
-28,151
| -8% | -$759K |
|
418
Kirby Corp
KEX
$6.93B
| $9.04M | 0.02% |
117,438
-7,538
| -6% | -$564K |
|
|
NBL
419
DELISTED
Noble Energy, Inc.
NBL
| $9.04M | 0.02% |
298,167
-78,431
| -21% | -$2.36M |
|
420
Ziff Davis
ZD
$1.98B
| $9.02M | 0.02% |
131,504
+35,762
| +37% | +$2.42M |
|
|
DOOR
421
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $9M | 0.02% |
146,654
-641
| -0.4% | -$43.1K |
|
422
Natural Gas Services Group
NGS
$477M
| $8.9M | 0.02% |
373,204
-49,148
| -12% | -$1.31M |
|
423
Gen Digital
GEN
$17.5B
| $8.86M | 0.02% |
342,603
-62,991
| -16% | -$1.71M |
|
|
USCR
424
DELISTED
U S Concrete, Inc.
USCR
| $8.85M | 0.02% |
146,494
-10,159
| -6% | -$754K |
|
425
Outfront Media
OUT
$5.5B
| $8.79M | 0.02% |
476,271
-23,699
| -5% | -$491K |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q1 2018 Portfolio in Review
As of Q1 2018, Loomis, Sayles & Company held 967 positions worth $47.1B, down 1.9% from $48B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Loomis, Sayles & Company's Q1 2018 filing shows 122 new, 219 increased, 464 reduced and 97 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 870,638 shares worth $70.6M. The largest sale was Amazon, an estimated $456M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
- Loomis, Sayles & Company's largest Q1 2018 buy was BioMarin Pharmaceuticals: 870,638 shares worth $70.6M.
- Loomis, Sayles & Company added most to Regeneron Pharmaceuticals in Q1 2018, an estimated $250M increase.
- Loomis, Sayles & Company's biggest Q1 2018 reduction was Amazon, cutting an estimated $456M.
- Loomis, Sayles & Company fully exited Analog Devices in Q1 2018, selling an estimated $151M.
- Loomis, Sayles & Company's ten largest holdings make up 35% of its $47.1B portfolio in Q1 2018.
- Loomis, Sayles & Company opened 122 new positions and closed 97 in Q1 2018.
- Loomis, Sayles & Company's portfolio value fell 1.9% quarter-over-quarter to $47.1B.
Based on Loomis, Sayles & Company's 13F filing for Q1 2018, filed 11 May 2018.